Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Add To Watchlist

TSX:LABS - Post Discussion

Medipharm Labs Corp > A secret pharmaceutical partner

View:

Post by Solid1 on Apr 06, 2024 4:21am

A secret pharmaceutical partner

As far as the generic of Epidiolex is concerned, I think it's more about the active ingredients in this drug... The GW/Jazz patents relate to the treatment of epilepsy.

If the pharma partner has a completely new treatment method in mind, there should be no major litigation as CBD is not patentable. From this perspective, any newly approved CBD-based drug is a generic of Epidiolex

182

Comment

Comment by subaru1i on Apr 06, 2024 9:24am

SEDDS used by LABS is a new treatment method because it provides a more efficient form of absorption in the body...wait for the generic Epidiolex launch in the U.S. news from LABS. We know that it is close because of the deal between Avicanna and LABS enabling LABS to use SEDDS which only becomes pertinent within commercialization....$$$$.

Comment

Comment by mdjbrown on Apr 06, 2024 10:41am

s1i, it is interesting that Avicanna has claimed proprietary SEDDS tech, when it appears there is SEDDS, SMEDDS, and SNEDDS tech used in several delivery system applications? https://mgmagazine.com/business/science-tech/cannabis-nanoemulsions-explained-finally/ https://ajphr.com/ajphrfiles/uploaddir/AJPHR_810072.pdf

Comment

Medipharm Labs Corp